AMA Moves to Ban Direct-To-Consumer Pharmaceutical Ads
According to the AMA, direct-to-consumer advertising of pharmaceuticals and medical devices drives up health care costs and should be banned. [More…]
Read MoreNew Study of Antipsychotic Use in Dementia
Call for guidelines for the use of antipsychotic drugs by people with dementia in nursing homes. New study suggests regular scrutiny of prescriptions and targeted education for physicians and nurses. [more…]
Read MoreAtypical Antipsychotic Shows Promise for New MDD Subtype
New to the diagnosis of major depressive disorder as of DSM-5 is the specifier “with mixed features.” According to DSM-5, “specifiers provide an opportunity to define a more homogeneous subgrouping of individuals with the disorder who share certain features (e.g., major depressive disorder, with mixed features) and to convey information that is relevant to the […]
Read MoreLong-Acting Injectable Antipsychotic To Prevent Relapse in First Episode Schizophrenia
Research published in JAMA Psychiatry demonstrated that long-acting, injectable, second-generation antipsychotic medication has tremendous potential to bring clinical stability to persons with first-episode schizophrenia. According to the authors, “long-acting medications are rarely used following a first episode of schizophrenia.” Patients with recent onset of schizophrenia (n=86) were randomized to receive long-acting injectable risperidone or oral […]
Read MoreAPA Joins ‘Choosing Wisely’ Project With Cautions on Antipsychotic Prescribing
APA has released a list of cautionary principles that should be considered when prescribing antipsychotic medications, noting that they are sometimes prescribed inappropriately. [More…]
Read More